Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000470:Alkaloids / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D016275:Atrial Function; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D003864:Depression, Chemical; D004285:Dogs; D004336:Drug Antagonism; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006329:Heart Conduction System / Q000187:drug effects*; D006846:Hydrocarbons, Halogenated / Q000037:antagonists & inhibitors; D010042:Ouabain / Q000037:antagonists & inhibitors; D013565:Sympatholytics / Q000494:pharmacology* / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy; D016276:Ventricular Function
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D006846:Hydrocarbons, Halogenated; D013565:Sympatholytics; D010042:Ouabain; D004837:Epinephrine